ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01302600
Recruitment Status : Completed
First Posted : February 24, 2011
Last Update Posted : November 22, 2016
Sponsor:
Collaborator:
Association Française contre les Myopathies (AFM), Paris
Information provided by (Responsible Party):
Hoffmann-La Roche